Liang Xue is a proteomics and bioinformatics leader with 8 years of industry experience driving mass spectrometry–based discovery at Pfizer, now modernizing proteomics infrastructure as Director for drug discovery. Trained with a PhD in Biochemistry and an MS in Computer Science, he blends experimental LC‑MS expertise with computational pipeline and machine learning workflow development to scale proteomics data systems. His career spans hands‑on assay design, database and pipeline engineering, and high‑throughput target engagement profiling from academic postdoctoral work to enterprise R&D. Based in Cambridge, he is comfortable translating complex biochemical questions into productionized data workflows that accelerate translational insights. An often‑overlooked strength is his cross-disciplinary fluency—he bridges wet lab nuance and software engineering rigor to deliver robust, reproducible proteomics solutions.
8 years of coding experience
18 years of employment as a software developer
Bachelor of Science (B.S.) Biology General, Bachelor of Science (B.S.) Biology General at University of Science and Technology of China
Doctor of Philosophy (Ph.D.) Biochemistry, Doctor of Philosophy (Ph.D.) Biochemistry at Purdue University
Master's degree Computer Science, Master's degree Computer Science at Northeastern University
Prosit offers high quality MS2 predicted spectra for any organism and protease as well as iRT prediction. When using Prosit is helpful for your research, please cite "Gessulat, Schmidt et al. 2019" DOI 10.1038/s41592-019-0426-7
Contributions:30 pushes in 1 year
doiirtproteasepredictionms2
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.